Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 
 
Litigation Image

Litigation

Post-Grant

Prosecution & Counseling

Fish has a global litigation practice with a proven record of successfully handling high-tech, high-stakes matters. We have a long history of litigating for technology pioneers, from the Wright brothers to today’s innovators in life sciences, electronics, medical devices, and more. Our trial skills are enriched by our broad and deep technical patent expertise – an expertise that sets us apart from general practice firms.

Fish recognizes that the only purpose of litigation is to achieve the client’s specific business objectives. We prepare every case with those business objectives in mind. When we can best serve our clients by resolving disputes short of trial, we do so. We are also uniquely positioned to handle any case that can benefit from understanding and explaining science and technology or presenting expert evidence.

Our attorneys enforce and defend an array of intellectual property claims for clients, ranging from some of the world’s largest corporations to individual inventors and innovators. Surveys show that we handle more patent litigation than does any other firm in the world, in both federal district courts and at the International Trade Commission.

Fish is dedicated to delivering the highest quality legal services and support to our clients. By design, our eFISHent Litigation approach enables us to achieve our clients’ objectives at a price that is an outstanding value – and we do it at all points of litigation. Learn more about our approach to eFISHent Litigation and our innovative eFISHencyTM systems here.

Recent Wins

Fish & Richardson Wins Two Jury Verdicts in Successive Weeks for Power Integrations

November 2018 – Fish & Richardson has won two jury verdicts in Delaware federal court for client Power Integrations, Inc. in its latest patent infringement battles against Fairchild Semiconductor. Read more here.

Fish & Richardson Wins for the Chamberlain Group

May 2018 – Fish & Richardson recently won a permanent injunction, treble damages and attorneys’ fees for the Chamberlain Group (CGI), an industry leader in the garage door industry, following an August 2017 jury verdict finding that Ryobi and Techtronic Industries (TTI) willfully infringed two of CGI’s patents. Read more here.

Fish Wins Federal Circuit Affirmance of Reversal of $200 Million Damages Against Gilead

April 2018 – Fish won a unanimous Federal Circuit opinion today that affirmed its June 2016 post-trial wipe-out of a $200 million jury verdict against client Gilead Sciences, Inc. after proving Merck had forfeited its right to assert its hepatitis C drug patents against Gilead because of litigation and business misconduct constituting “unclean hands.” Read more about this precedential opinion here and here.

Roaring Back From the Largest-Ever Patent Verdict

February 2018 – In late 2016, Gilead Sciences, Inc. and a Fish & Richardson trial team led by Jonathan Singer were hit with a $2.5 billion jury verdict, the largest ever recorded in a U.S. patent infringement case. Read how they turned the tables.


Highlights

Search Fish Team

Search by Letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
No matches
Litigation

Litigation Team

What's Trending in Litigation

Filter by
News
January 16, 2019
Fish & Richardson Grows Firm With 14 Associates
Fish & Richardson Grows Firm With 14 Associates
Press Release
News
January 15, 2019
Fish & Richardson Named Law360 IP Practice Group of the Year
Fish & Richardson Named <i>Law360</i> IP Practice Group of the Year
Press Release
Fish Litigation Blog
January 14, 2019
Biosimilars 2018 Year in Review
Biosimilars 2018 Year in Review
Authors: Philip K. Chen, Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
IP Litigation
Life Sciences
Fish Litigation Blog
January 10, 2019
EDTX & NDTX Monthly Wrap-Up – December 2018
EDTX & NDTX Monthly Wrap-Up – December 2018
Author: Aaron Pirouznia
IP Litigation
News
January 10, 2019
Fish & Richardson Obtains Denial of Cert at U.S. Supreme Court for Gilead Sciences in Long-Running Patent Battle with Merck Over Hepatitis C Drugs
Fish & Richardson Obtains Denial of Cert at U.S. Supreme Court for Gilead Sciences in Long-Running Patent Battle with Merck Over Hepatitis C Drugs
Press Release
News
January 3, 2019
Four Fish & Richardson Attorneys Named 2018 “Rising Stars” by Managing Intellectual Property Magazine
Four Fish & Richardson Attorneys Named 2018 “Rising Stars”  by <i>Managing Intellectual Property</i> Magazine
Press Release
News
January 3, 2019
Fish & Richardson Receives Two 2018 “Attorney of the Year” Awards from Minnesota Lawyer
Fish & Richardson Receives Two 2018 “Attorney of the Year” Awards from <i>Minnesota Lawyer</i>
Press Release
Event
January 17th, 2019 | 1:00 pm EST
Webinar | 2018 Biosimilars – A Year in Review
Webinar | 2018 Biosimilars – A Year in Review
Webinar
News
December 12, 2018
Corporate Counsel Profiles Juanita Brooks
<i>Corporate Counsel</i> Profiles Juanita Brooks
Press Release
News
December 3, 2018
Esha Bandyopadhyay and J. Kain Day Author Article in Daily Journal "The Law of Unintended Consequences at Federal Circuit"
Esha Bandyopadhyay and J. Kain Day Author Article in <i>Daily Journal</i>
Articles
News
November 27, 2018
Fish & Richardson Principal Jonathan Singer Named 2018 Life Sciences MVP of the Year by Law360
Fish & Richardson Principal Jonathan Singer Named 2018 Life Sciences MVP of the Year by <i>Law360</i>
Press Release
News
November 20, 2018
Fish & Richardson Wins Two Jury Verdicts in Successive Weeks for Power Integrations
Fish & Richardson Wins Two Jury Verdicts in Successive Weeks for Power Integrations
Press Release
load more topics